PROGNOSIS AND CONDITIONAL PROBABILITY SURVIVAL ANALYSIS OF ADRENAL CORTICAL CARCINOMA: A POPULATION LEVEL STUDY

Wenjun Xiao,Yongqiang Huang,Fangning Wan,Yao Zhu,Dingwei Ye
DOI: https://doi.org/10.1016/j.juro.2018.02.3052
2018-01-01
Abstract:You have accessJournal of UrologyAdrenal1 Apr 2018MP03-09 PROGNOSIS AND CONDITIONAL PROBABILITY SURVIVAL ANALYSIS OF ADRENAL CORTICAL CARCINOMA: A POPULATION LEVEL STUDY WENJUN XIAO, Yongqiang Huang, Fangning Wan, Yao Zhu, and Dingwei Ye WENJUN XIAOWENJUN XIAO More articles by this author , Yongqiang HuangYongqiang Huang More articles by this author , Fangning WanFangning Wan More articles by this author , Yao ZhuYao Zhu More articles by this author , and Dingwei YeDingwei Ye More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.3052AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Adrenal cortical carcinoma (ACC) is a rare malignancy that originates in the adrenal cortex. Surgery is the single most important intervention in the treatment of nonmetastatic ACC. Besides, disease prognosis is not constant over time, so the conditional survival (CS) needs to be evaluated. METHODS The Surveillance, Epidemiology and End Results (SEER) database was queried for patients aged >18 years diagnosed with ACC between 2010 and 2014. Demographic, clinical and pathologic information were collected as well as survival status as of December 31, 2014. Patients with unavailable pathologic staging information or follow-up information were excluded. Survival analysis were performed. CS(y/x) is defined as the probability of surviving an additional y years, S(x+y), given that the patient has already survived x years, S(x): CS(y/x)=S(x+y)/S(x). RESULTS A total of 353 cases were selected, and 112 cases had metastatic disease. Patients diagnosed with or without metastases had the median overall survival (OS) of 6 and 40 months, respectively. Factors independently associated with poor prognosis were older age, higher tumor grade, diagnosed with metastases and failure to undergo surgery. Besides, lymph node involvement was also unfavorable prognostic factor for patients without metastases. However, the negetive prognostic factors of patients diagnosed with metastases were just older age and failure to undergo surgery. CS estimates were more encourging than static survival probabilities. The gains in 6-months CS over time were more pronounced in patients with poor prognostic factors (Figure). The differences of CS between the different prognostic factor groups decreased with time from diagnosis, or even disappeared. Within 24 months, the CS of cases with older age or higher tumor grade might reach the level of the corresponding subgroups with younger age or lower tumor grade (b and e). This duration for cases diagnosed with distant metastases was 30 months (c). It may be impossible for CS of the cases failing to undergo surgery to reach the level of the cases undergoing surgery before the actual survival rate decrease to nearly zero (d). This also indicated that patients without surgery had a very poor prognosis. CONCLUSIONS These findings provided a new perspective for understanding the prognosis of ACC. The surgery play a very important role in the prognosis of ACC, even for the patients diagnosed with distant metastases. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e24-e25 Advertisement Copyright & Permissions© 2018MetricsAuthor Information WENJUN XIAO More articles by this author Yongqiang Huang More articles by this author Fangning Wan More articles by this author Yao Zhu More articles by this author Dingwei Ye More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?